Combination anti-amyloid therapy for preclinical Alzheimer's disease — Paul S. Aisen (UNIVERSITY OF SOUTHERN CALIFORNIA)
PROJECT SUMMARY This is a multi-PI application for an R01 award under PAR-18-513. The proposed project titled “Combination Anti-Amyloid Therapy in Preclinical Alzheimer's Disease” is a multicenter ran
| Project title | Combination anti-amyloid therapy for preclinical Alzheimer's disease |
|---|---|
| Project number | 5R01AG061848-05 |
| PI name | Paul S. Aisen |
| Institution | UNIVERSITY OF SOUTHERN CALIFORNIA |
| Funding mechanism | R01 |
| Agency | NIA |
| Award amount | $8.72M |
| Fiscal year | 2024 |
| Project start | 2018-09-30T00:00:00 |
| Project end | 2025-05-31T00:00:00 |
| Abstract | PROJECT SUMMARY This is a multi-PI application for an R01 award under PAR-18-513. The proposed project titled “Combination Anti-Amyloid Therapy in Preclinical Alzheimer's Disease” is a multicenter ran |
| Key terms | <A β-42><A β42><A-beta 42><A-beta42><AD dementia><Abeta-42><Abeta42><Activities of Daily Living><Act |
$799/mo
Try GrantRadar →